期刊文献+

甲型肝炎病毒免疫控制研究进展 被引量:2

Progress on Immune Control of Hepatitis A Virus
下载PDF
导出
摘要 对甲型肝炎病毒(HAV)发病机理和免疫调控的研究近年来重新受到关注。在发展中国家感染者的平均年龄增加,导致机制尚不明确的更严重的肝炎。而且,从HAV和丙型肝炎病毒(HCV)的免疫对比来看,这两种正链RNA病毒感染结果完全不同。HCV比HAV复制效率低,导致HCV蛋白表达量低,因此对IFN信号传导的拮抗作用较低。有研究发现循环的HAV病毒颗粒隐藏在膜里,导致先天免疫和抗体介导中和作用的激活。同时还考虑到CD4^+辅助T细胞对CD8^+细胞毒性T细胞对抗病毒免疫和肝损伤的作用,提出了一种非细胞毒性的HAV感染免疫控制模型。 Despite the limited progress made in the past two to three decades,researches on the pathogenesis and immune regulation of Hepatitis A virus(HAV)have received renewed attention.From a public health point of view,the average age of infections in developing countries has increased,resulting in more severe hepatitis that mechanism is not clear.Furthermore,from the immunological comparison of HAV and hepatitis C virus(HCV),the results of these two positive-stranded RNA virus infections are quite different.HCV has a lower replication efficiency than HAV,resulting in low HCV protein expression and therefore low antagonism of IFN signaling.Studies have found that circulating HAV particles hidden in the membrane lead to innate immunity and antibody-mediated neutralization.The effect of CD4^+ helper cells on antiviral immunity and liver injury by CD8^+cytotoxic T cells were also considered,and a non-cytotoxic immune control model of HAV infection was also proposed.
作者 杜江龙 薛宇佳 冶昡青 杨学才 曹欣 DU Jiang-long;XUE Yu-jia;YE Xuan-qing;YANG Xue-cai;CAO Xin(Life Science and Engineering College,Northivest University For Nationalities,Lanzhou,Gansu,730030,China)
出处 《动物医学进展》 北大核心 2019年第4期112-115,共4页 Progress In Veterinary Medicine
关键词 甲型肝炎病毒 丙型肝炎病毒 先天免疫 T细胞 Hepatitis A virus Hepatitis C virus innate immunity T cell
  • 相关文献

参考文献1

二级参考文献36

  • 1Vik-Mo E O, Nyakas M, Mikkelsen B V, et al. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma[ J]. Cancer Immunol Immunother, 2013, 62(9) : 1499 - 1509.
  • 2Allard S D, De Keersmaecker B, de Goede A L, et al. A phase I/Ila immunotherapy trial of HIV-l-infected patients with Tat, Rev and Nef expressing dendritic cellsfoUowed by treatment interruption[J]. Clin Immunol, 2012, 142(3) : 252 -268.
  • 3Roesle E, Weiss R, WeinbeeT E E, et al. Imratmize and disappear- safety-op'tnnized mRNA vaccination with a panel of 29 allergens [J/OL]. J Allergy Clin Immunol, 2009, 124(5) : 1070 - 1077.doi: 10. 1016/j. jaci. 2009.06. 036. Epub 2009 Aug 8. _ _.
  • 4Gros F, Gilbert W, Hiatt H H, et al. Molecular and biological characterization of messenger RNA [ J ]. Cold Spring Harb Syrup Quant Biol, 1961, 26:111-132.
  • 5Wolff J A, Malone R W, Williams P, et al. Direct gene transfer into mouse muscle in vivo [ J ]. Science, 1990, 247 ( 4949 Pt 1 ) : 1465 - 1468.
  • 6Martinon F, Krishnan S, Lenzen G, et al. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA [ J ]. Eur J Immunol, 1993, 23(7): 1719-1722.
  • 7Grudzien-Nogalska E, Kowalska J, Su W, et al. Synthetic mRNAs with superior translation and stability properties [ J ]. Methods Mol Bid, 2013, 969:55 -72.
  • 8Wilgenhof S, Van Nuffel A M, Benteyn D, et al. A phase I B study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients [ J ]. Ann Oncol, 2013, 24(10) : 2686 -2693.
  • 9Van Lint S, Goyvaerts C, Maenhout S, et al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy [ J ]. Cancer Res, 2012, 72(7): 1661 -1671.
  • 10Van Nuffel A M, Benteyn D, Wflgenhof S, et al. Intravenous and intradennal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-Mlc melanoma patient [ J ]. Cancer Immunol Inmaunother, 2012, 61 ( 7 ) : 1033 - 1043.

共引文献6

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部